Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event.
about
White paper: landscape on technical and conceptual requirements and competence framework in drug/disease modeling and simulation.Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson diseaseMechanism-based pharmacodynamic modeling.Leveraging model-informed approaches for drug discovery and development in the cardiovascular space.
P2860
Model-based decision making in early clinical development: minimizing the impact of a blood pressure adverse event.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Model-based decision making in ...... blood pressure adverse event.
@en
Model-based decision making in ...... blood pressure adverse event.
@nl
type
label
Model-based decision making in ...... blood pressure adverse event.
@en
Model-based decision making in ...... blood pressure adverse event.
@nl
prefLabel
Model-based decision making in ...... blood pressure adverse event.
@en
Model-based decision making in ...... blood pressure adverse event.
@nl
P2093
P2860
P1433
P1476
Model-based decision making in ...... blood pressure adverse event.
@en
P2093
Carol Addy
Craig Shadle
Gregory A Winchell
John Wagner
Julie A Stone
Keith Gottesdiener
Kimberly Manser
Mark Stroh
Michelle Groff
P2860
P2888
P304
P356
10.1208/S12248-009-9083-6
P407
P577
2009-02-06T00:00:00Z
P5875
P6179
1031562326